Taiwan Stock Exchange · Healthcare
TaiDoc Technology stock from India: price, numbers and tax
TaiDoc Technology (4736) is not currently available to trade on Paasa; this guide covers the price, the numbers and the Indian tax treatment.
By Paasa · Updated
TaiDoc Technology at a glance
- Price
- NT$130.00+NT$0.00 (0.00%)
- Market cap
- NT$12.40B
- Day range
- NT$129.00 – NT$131.50
- P/E
- 5.04
- Dividend yield
- 3.90%
- Volume
- 97.49K
- 1 month
- +2.77%
- 6 months
- +16.89%
- YTD
- +17.85%
- 1 year
- +18.83%
- 5 years
- -18.18%
TaiDoc Technology statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | NT$4.2B | NT$4.6B | NT$4.8B | NT$9.6B | NT$6.5B |
| Gross profit | NT$1.9B | NT$2.1B | NT$2.1B | NT$5.6B | NT$3.2B |
| Operating income | NT$956.2M | NT$805.2M | NT$968.0M | NT$4.2B | NT$2.1B |
| Net income | NT$1.4B | NT$1.2B | NT$1.0B | NT$3.4B | NT$2.0B |
| Earnings per share | NT$15.12 | NT$12.10 | NT$10.67 | NT$36.03 | NT$21.35 |
| EBITDA | NT$1.1B | NT$1.7B | NT$1.2B | NT$4.6B | NT$2.7B |
| Total assets | NT$12.8B | NT$12.2B | NT$11.9B | NT$12.9B | NT$10.5B |
| Total debt | NT$1.2B | NT$1.1B | NT$1.1B | NT$636.3M | NT$1.3B |
| Cash and short-term investments | NT$5.2B | NT$4.9B | NT$4.7B | NT$5.0B | NT$3.1B |
| Shareholders' equity | NT$9.8B | NT$9.1B | NT$8.9B | NT$9.7B | NT$7.4B |
| Operating cash flow | NT$853.4M | −NT$181.4M | NT$1.2B | NT$3.2B | NT$1.9B |
| Free cash flow | NT$602.2M | −NT$536.6M | NT$1.1B | NT$2.7B | NT$1.6B |
| Capital expenditure | −NT$251.2M | −NT$355.2M | −NT$113.7M | −NT$507.9M | −NT$326.6M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in TWD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Medigen Vaccine Biologics | 6547.TWO | $62.60 | $20.58B |
| Visco Vision | 6782.TW | NT$237.50 | NT$14.96B |
| Excelsior Medical | 4104.TW | NT$72.70 | NT$13.69B |
| Vizionfocus | 4771.TW | NT$213.50 | NT$12.53B |
| Foresee Pharmaceuticals | 6576.TWO | $79.10 | $12.46B |
| Universal Vision Biotechnology | 3218.TWO | $134.00 | $11.35B |
| Standard Chem & Pharm | 1720.TW | NT$56.10 | NT$11.03B |
| United Orthopedic | 4129.TWO | $82.60 | $7.97B |
Peers as grouped by the data provider. This is not an investment recommendation.
Why invest in TaiDoc Technology from India
What TaiDoc Technology does
TaiDoc Technology Corporation, established in 1998 and based in New Taipei City, Taiwan, is a leading global producer and distributor of a wide array of medical devices. The company's comprehensive product catalog features advanced in vitro diagnostics, including multi-parameter monitoring systems, convenient point-of-care testing (POCT) devices, and precision lancet and lancing tools. TaiDoc Technology operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
What tax do I pay in India when I sell TaiDoc Technology shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the TWD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain.